From £6.99 per month
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares


Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Kingfisher keeps on hoping for more and more “home nesting” by us all

By Chris Bailey | Tuesday 20 September 2022

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Some GSK plc (GSK) shareholders have sold their Haleon (HLN) spin-off shares and some have not. I belong in the latter group on the basis that today’s half one numbers are a classic double or quits moment, based far more on the conference call being held by “one of the world's largest providers of specialist oral health” later today. I look forward to sharing some thoughts with you all on this tomorrow – as shown by the share price rise this morning, the numbers were alright…but what really matters is where the group is going over the rest of the decade. Meanwhile, a couple of months ago I wrote on Kingfisher (KGF).

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Thursday »


Bearcast issue update: all should be well



Oracle Power: Cynical Foul

Time left: 14:01:30